Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Research Report 2023

Report ID: 1897548 | Published Date: Oct 2024 | No. of Page: 106 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Overview
    1.1 Product Overview and Scope of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines
    1.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Type
        1.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Live Vaccines
        1.2.3 Killed Vaccines
    1.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Segment by Application
        1.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Comparison by Application: (2022-2028)
        1.3.2 Government Tender
        1.3.3 Market Sales
    1.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Estimates and Forecasts
        1.4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue 2017-2028
        1.4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales 2017-2028
        1.4.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028
2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competition by Manufacturers
    2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Sites, Area Served, Product Type
    2.5 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competitive Situation and Trends
        2.5.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players Market Share by Revenue
        2.5.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Retrospective Market Scenario by Region
    3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
        3.3.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country
        3.3.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country
        3.3.3 the United States
        3.3.4 Canada
    3.4 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
        3.4.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country
        3.4.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 UK
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Region
        3.5.1 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region
        3.5.2 Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
        3.6.1 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country
        3.6.2 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Facts & Figures by Country
        3.7.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country
        3.7.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Analysis by Type
    4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2017-2022)
    4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2017-2022)
    4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2017-2022)
5 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Analysis by Application
    5.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2017-2022)
    5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2017-2022)
    5.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 CAHIC
        6.1.1 CAHIC Corporation Information
        6.1.2 CAHIC Description and Business Overview
        6.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.1.5 CAHIC Recent Developments/Updates
    6.2 Merial
        6.2.1 Merial Corporation Information
        6.2.2 Merial Description and Business Overview
        6.2.3 Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.2.5 Merial Recent Developments/Updates
    6.3 MSD Animal Health
        6.3.1 MSD Animal Health Corporation Information
        6.3.2 MSD Animal Health Description and Business Overview
        6.3.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.3.5 MSD Animal Health Recent Developments/Updates
    6.4 Chopper Biology
        6.4.1 Chopper Biology Corporation Information
        6.4.2 Chopper Biology Description and Business Overview
        6.4.3 Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.4.5 Chopper Biology Recent Developments/Updates
    6.5 Ceva
        6.5.1 Ceva Corporation Information
        6.5.2 Ceva Description and Business Overview
        6.5.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.5.5 Ceva Recent Developments/Updates
    6.6 ChengDu Tecbond
        6.6.1 ChengDu Tecbond Corporation Information
        6.6.2 ChengDu Tecbond Description and Business Overview
        6.6.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.6.5 ChengDu Tecbond Recent Developments/Updates
    6.7 Veterinary
        6.6.1 Veterinary Corporation Information
        6.6.2 Veterinary Description and Business Overview
        6.6.3 Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.7.5 Veterinary Recent Developments/Updates
    6.8 Ringpu Biology
        6.8.1 Ringpu Biology Corporation Information
        6.8.2 Ringpu Biology Description and Business Overview
        6.8.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.8.5 Ringpu Biology Recent Developments/Updates
    6.9 Qilu Animal
        6.9.1 Qilu Animal Corporation Information
        6.9.2 Qilu Animal Description and Business Overview
        6.9.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.9.5 Qilu Animal Recent Developments/Updates
    6.10 DHN
        6.10.1 DHN Corporation Information
        6.10.2 DHN Description and Business Overview
        6.10.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.10.5 DHN Recent Developments/Updates
    6.11 CAVAC
        6.11.1 CAVAC Corporation Information
        6.11.2 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
        6.11.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.11.5 CAVAC Recent Developments/Updates
    6.12 Komipharm
        6.12.1 Komipharm Corporation Information
        6.12.2 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
        6.12.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.12.5 Komipharm Recent Developments/Updates
    6.13 Agrovet
        6.13.1 Agrovet Corporation Information
        6.13.2 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
        6.13.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.13.5 Agrovet Recent Developments/Updates
    6.14 Bioveta
        6.14.1 Bioveta Corporation Information
        6.14.2 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
        6.14.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.14.5 Bioveta Recent Developments/Updates
    6.15 Jinyu Bio-Technology
        6.15.1 Jinyu Bio-Technology Corporation Information
        6.15.2 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
        6.15.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.15.5 Jinyu Bio-Technology Recent Developments/Updates
    6.16 Institutul Pasteur
        6.16.1 Institutul Pasteur Corporation Information
        6.16.2 Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
        6.16.3 Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.16.5 Institutul Pasteur Recent Developments/Updates
    6.17 MVP
        6.17.1 MVP Corporation Information
        6.17.2 MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
        6.17.3 MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.17.5 MVP Recent Developments/Updates
    6.18 Tecon
        6.18.1 Tecon Corporation Information
        6.18.2 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
        6.18.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.18.5 Tecon Recent Developments/Updates
    6.19 Zoetis
        6.19.1 Zoetis Corporation Information
        6.19.2 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Description and Business Overview
        6.19.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Portfolio
        6.19.5 Zoetis Recent Developments/Updates
7 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Cost Analysis
    7.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines
    7.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors List
    8.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers
9 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Dynamics
    9.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends
    9.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers
    9.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Challenges
    9.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints
10 Global Market Forecast
    10.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Type (2023-2028)
    10.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Application (2023-2028)
    10.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Sites and Area Served
    Table 11. Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2017-2022) & (K Units)
    Table 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2017-2022)
    Table 17. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2017-2022)
    Table 19. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2017-2022) & (K Units)
    Table 20. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2017-2022)
    Table 21. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2017-2022)
    Table 23. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2017-2022)
    Table 25. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2017-2022)
    Table 33. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Country (2017-2022)
    Table 39. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2017-2022) & (K Units)
    Table 40. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2017-2022)
    Table 41. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Type (2017-2022)
    Table 43. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units) by Application (2017-2022)
    Table 45. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2017-2022)
    Table 46. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Application (2017-2022)
    Table 48. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2017-2022) & (USD/Unit)
    Table 49. CAHIC Corporation Information
    Table 50. CAHIC Description and Business Overview
    Table 51. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 53. CAHIC Recent Developments/Updates
    Table 54. Merial Corporation Information
    Table 55. Merial Description and Business Overview
    Table 56. Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 58. Merial Recent Developments/Updates
    Table 59. MSD Animal Health Corporation Information
    Table 60. MSD Animal Health Description and Business Overview
    Table 61. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 63. MSD Animal Health Recent Developments/Updates
    Table 64. Chopper Biology Corporation Information
    Table 65. Chopper Biology Description and Business Overview
    Table 66. Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 68. Chopper Biology Recent Developments/Updates
    Table 69. Ceva Corporation Information
    Table 70. Ceva Description and Business Overview
    Table 71. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 73. Ceva Recent Developments/Updates
    Table 74. ChengDu Tecbond Corporation Information
    Table 75. ChengDu Tecbond Description and Business Overview
    Table 76. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 78. ChengDu Tecbond Recent Developments/Updates
    Table 79. Veterinary Corporation Information
    Table 80. Veterinary Description and Business Overview
    Table 81. Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 83. Veterinary Recent Developments/Updates
    Table 84. Ringpu Biology Corporation Information
    Table 85. Ringpu Biology Description and Business Overview
    Table 86. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 88. Ringpu Biology Recent Developments/Updates
    Table 89. Qilu Animal Corporation Information
    Table 90. Qilu Animal Description and Business Overview
    Table 91. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 92. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 93. Qilu Animal Recent Developments/Updates
    Table 94. DHN Corporation Information
    Table 95. DHN Description and Business Overview
    Table 96. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 97. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 98. DHN Recent Developments/Updates
    Table 99. CAVAC Corporation Information
    Table 100. CAVAC Description and Business Overview
    Table 101. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 102. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 103. CAVAC Recent Developments/Updates
    Table 104. Komipharm Corporation Information
    Table 105. Komipharm Description and Business Overview
    Table 106. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 107. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 108. Komipharm Recent Developments/Updates
    Table 109. Agrovet Corporation Information
    Table 110. Agrovet Description and Business Overview
    Table 111. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 113. Agrovet Recent Developments/Updates
    Table 114. Bioveta Corporation Information
    Table 115. Bioveta Description and Business Overview
    Table 116. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 118. Bioveta Recent Developments/Updates
    Table 119. Jinyu Bio-Technology Corporation Information
    Table 120. Jinyu Bio-Technology Description and Business Overview
    Table 121. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 123. Jinyu Bio-Technology Recent Developments/Updates
    Table 124. Institutul Pasteur Corporation Information
    Table 125. Institutul Pasteur Description and Business Overview
    Table 126. Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 128. Institutul Pasteur Recent Developments/Updates
    Table 129. MVP Corporation Information
    Table 130. MVP Description and Business Overview
    Table 131. MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 132. MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 133. MVP Recent Developments/Updates
    Table 134. Tecon Corporation Information
    Table 135. Tecon Description and Business Overview
    Table 136. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 137. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 138. Tecon Recent Developments/Updates
    Table 139. Zoetis Corporation Information
    Table 140. Zoetis Description and Business Overview
    Table 141. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 142. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
    Table 143. Zoetis Recent Developments/Updates
    Table 144. Production Base and Market Concentration Rate of Raw Material
    Table 145. Key Suppliers of Raw Materials
    Table 146. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors List
    Table 147. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers List
    Table 148. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Trends
    Table 149. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers
    Table 150. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Challenges
    Table 151. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints
    Table 152. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Type (2023-2028) & (K Units)
    Table 153. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share Forecast by Type (2023-2028)
    Table 154. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 155. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share Forecast by Type (2023-2028)
    Table 156. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Application (2023-2028) & (K Units)
    Table 157. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share Forecast by Application (2023-2028)
    Table 158. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 159. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share Forecast by Application (2023-2028)
    Table 160. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Forecast by Region (2023-2028) & (K Units)
    Table 161. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share Forecast by Region (2023-2028)
    Table 162. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 163. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share Forecast by Region (2023-2028)
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines
    Figure 2. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Live Vaccines Product Picture
    Figure 4. Killed Vaccines Product Picture
    Figure 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Application in 2021 & 2028
    Figure 6. Government Tender
    Figure 7. Market Sales
    Figure 8. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (2017-2028) & (K Units)
    Figure 11. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Manufacturers in 2021
    Figure 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Players: Market Share by Revenue in 2021
    Figure 14. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2017-2022)
    Figure 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region in 2021
    Figure 17. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2017-2022)
    Figure 18. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region in 2021
    Figure 19. the United States Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. UK Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Taiwan Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Mexico Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Brazil Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Argentina Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Turkey Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Saudi Arabia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. UAE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Sales Market Share of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Type (2017-2022)
    Figure 42. Manufacturing Cost Structure of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines
    Figure 43. Manufacturing Process Analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines
    Figure 44. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industrial Chain Analysis
    Figure 45. Channels of Distribution
    Figure 46. Distributors Profiles
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Zoetis
Frequently Asked Questions
Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Lyophilized IVIG

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More